Compass Therapeutics Inc (CMPX)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
80 GUEST STREET BOSTON, MA 02135

Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, develops proprietary antibody-based therapeutics to treat multiple human diseases.

View SEC Filings from CMPX instead.

View recent insider trading info

Compass Therapeutics Inc YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding CMPX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CMPX

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-09-08 by SCHUETZ THOMAS J.
  • 4: filed on 2022-09-01 by SCHUETZ THOMAS J.
  • 4: filed on 2022-08-10 by SCHUETZ THOMAS J.
  • 4: filed on 2022-08-02 by SCHUETZ THOMAS J.
  • 4: filed on 2022-06-21 by SCHUETZ THOMAS J.
  • 4: filed on 2022-06-17 by SCHUETZ THOMAS J.
  • 4: filed on 2022-06-13 by SCHUETZ THOMAS J.
  • 4: filed on 2022-06-07 by SCHUETZ THOMAS J.
  • 4: filed on 2022-06-01 by SCHUETZ THOMAS J.
  • 4: filed on 2022-05-26 by SCHUETZ THOMAS J.

    • Events (8k)

  • 8-K: filed on 2022-08-19:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-01:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.02: Termination of a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits

    • Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    75 Thousand total shares from 5 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SCHUETZ THOMAS J. CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 5,406,873 2022-09-07 16

    ORBIMED ADVISORS LLC

    ORBIMED CAPITAL GP V LLC

    ORBIMED GENESIS GP LLC

    • Director
    • 10% Owner
    		 14,817,994 2022-05-11 3

    GORDON CARL L

    • Director
    • 10% Owner
    		 14,817,994 2022-05-11 4

    GRAY MARY ANN

    • Director
    		 0 2022-04-26 2

    CHINIARA ELLEN

    • Director
    		 0 2022-04-26 2

    SQUINTO STEPHEN P

    • Director
    		 30,000 2022-02-18 1

    KAPLAN BRETT

    • Director
    		 30,000 2022-02-18 1

    BISKER-LEIB VERED CHIEF OPERATING OFFICER

    • Officer
    		 500,000 2022-02-18 3

    FERNEAU PHILIP

    • Director
    		 30,000 2022-02-18 1

    KALLED SUSAN CHIEF SCIENTIFIC OFFICER

    • Officer
    		 60,000 2022-02-18 2

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    SCHUETZ THOMAS J. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-09-08 10:12:23 -0400 2022-09-07 P 15,000 $3.03 a 5,406,873 direct

    SCHUETZ THOMAS J. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-09-01 14:37:05 -0400 2022-09-01 P 15,000 $2.83 a 5,391,873 direct 0.0 0.0 1 0.0 1

    SCHUETZ THOMAS J. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-08-17 16:06:55 -0400 2022-08-17 P 15,000 $3.05 a 5,376,873 direct 0.0 0.6689 2.0067 3 0.0 1

    SCHUETZ THOMAS J. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-08-10 10:51:32 -0400 2022-08-10 P 15,000 $2.64 a 5,361,873 direct 2.6119 11.9403 12.6866 5 0.0 1

    SCHUETZ THOMAS J. - Director - Officer CHIEF EXECUTIVE OFFICER

    		2022-08-02 09:15:40 -0400 2022-08-01 P 15,000 $2.58 a 5,346,873 direct -1.5209 1.5209 1.5209 6 -2.6616 3

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 15:15:04 UTC -7.1234 9.4434 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 14:45:03 UTC -7.1234 9.4434 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 14:15:03 UTC -7.1234 9.4434 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 13:45:03 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 13:15:03 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-08 12:45:03 UTC -6.9351 9.2551 95000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 22:15:05 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 21:45:05 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 21:15:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 20:45:03 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 20:15:05 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 19:45:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 19:15:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 18:45:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 18:15:05 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 17:45:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 17:15:05 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 16:45:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 16:15:04 UTC -6.9351 9.2551 100000
    COMPASS THERAPEUTICS INC CMPX 2022-09-07 15:45:04 UTC -6.9351 9.2551 100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    Elevate your investments